Starpharma (SPHRY) News Today $0.60 +0.05 (+8.93%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Starpharma (OTCMKTS:SPHRY) Trading Down 10.9% - Time to Sell?December 20 at 1:55 AM | americanbankingnews.comStarpharma CEO Receives Major Performance Rights IssuanceDecember 12, 2024 | markets.businessinsider.comStarpharma Issues Unquoted Securities to Boost Employee IncentivesDecember 12, 2024 | markets.businessinsider.comStarpharma Holdings Reports Successful AGM ResultsNovember 29, 2024 | tipranks.comStarpharma Holdings Schedules Reconvened AGM for Key VoteNovember 26, 2024 | tipranks.comStarpharma AGM Results Highlight Voting ChallengesNovember 26, 2024 | tipranks.comStarpharma Holdings Highlights Strategic Advances in 2024November 25, 2024 | tipranks.comStarpharma Highlights Dendrimer Technology at Healthcare ConferenceNovember 18, 2024 | markets.businessinsider.comStarpharma Showcases Dendrimer Innovations at Microcap ConferenceOctober 29, 2024 | markets.businessinsider.comStarpharma Holdings Ltd. ADRMarch 14, 2024 | wsj.comStarpharma's VivaGel Approval Denied By FDAFebruary 19, 2024 | markets.businessinsider.comASX Health Stocks: Starpharma suffers setback as FDA rejects appeal, shares down 10pcFebruary 18, 2024 | msn.comStarpharma Holdings Ltd SPLJanuary 19, 2024 | morningstar.comStarpharma Holdings LimitedJanuary 6, 2024 | afr.comStarpharma Holdings Limited (SPHRY)November 29, 2023 | finance.yahoo.comStarpharma Holdings (SPHRY) Earnings Dates & ReportsNovember 8, 2023 | investing.comStarpharma: Patience Needed, But A Lot To LikeJuly 27, 2023 | seekingalpha.comThe Ethical Investor: Why Starpharma and these ASX biotechs could stop the next infectious disease outbreakJune 9, 2023 | msn.comVIRALEZE Nasal Spray to be distributed in Hong Kong and MacauOctober 24, 2022 | finance.yahoo.comStarpharma presents compelling data in Prostate Cancer at ESMOSeptember 12, 2022 | finance.yahoo.comStarpharma signs new DEP® agreement with MSDAugust 10, 2022 | finance.yahoo.comStarpharma: VIRALEZE Nasal Spray Protects Against Highly Infectious Omicron in Viral Challenge Model - Before or After Viral ExposureJuly 20, 2022 | finanznachrichten.deStarpharma Holdings Ltd. ADR (SPHRY)January 12, 2022 | nasdaq.comWhat is happening to the Starpharma (ASX:SPL) share price today?December 13, 2021 | msn.comStarpharma (ASX:SPL) share price shoots 6% higher on Roche agreementDecember 6, 2021 | msn.comWhy is the Starpharma (ASX:SPL) share price trading at 52-week lows?November 19, 2021 | msn.comPerth businesswoman Kim Tran launches new business, scores supply deal with StarpharmaOctober 28, 2021 | markets.businessinsider.comStarpharma (ASX:SPL) share price lifts on supply and distribution dealOctober 26, 2021 | msn.comVIRALEZE™ antiviral nasal spray launched in ADMENTA Italia Group pharmacies in ItalyOctober 8, 2021 | finance.yahoo.comUS Patent and Trademark Office grants new patent for DEP® cabazitaxel, one of Starpharma’s phase 2 clinical-stage cancer treatmentsSeptember 15, 2021 | apnews.comUS Patent and Trademark Office grants new patent for DEP® cabazitaxel, one of Starpharma's phase 2 clinical-stage cancer treatmentsSeptember 15, 2021 | finance.yahoo.comStarpharma (ASX:SPL) share price tanks 3% on 67% revenue dropAugust 26, 2021 | msn.comWhy the Starpharma (ASX:SPL) share price is racing 7% higher todayJuly 26, 2021 | msn.com Get Starpharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SPHRY and its competitors with MarketBeat's FREE daily newsletter. Email Address Wall Street Icon: “You must get on the right side of this thing” (Ad)I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years. This market shakeup is going to be much more intense. SPHRY Media Mentions By Week SPHRY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SPHRY News Sentiment▼0.000.59▲Average Medical News Sentiment SPHRY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SPHRY Articles This Week▼10▲SPHRY Articles Average Week Get Starpharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SPHRY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LUNA News Today CBWTF News Today ONMD News Today BIAF News Today FOXO News Today ISPC News Today USRM News Today DNAG News Today IQV News Today ICLR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SPHRY) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Starpharma Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Starpharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SPHRY Stock Alerts